These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27443732)

  • 41. Herbs and dietary supplements in the European Union: a review of the regulations with special focus on Germany and Poland.
    Konik EA; Jungling RC; Bauer BA
    J Diet Suppl; 2011 Mar; 8(1):43-57. PubMed ID: 22432634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Food additives used in meat processing according to the Polish and European Union legislation.
    Uradziński J; Weiner M
    Pol J Vet Sci; 2003; 6(2):173-6. PubMed ID: 12817787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pesticides: Seeking answers amid a toxic debate.
    Eisenstein M
    Nature; 2015 May; 521(7552):S52-5. PubMed ID: 25992672
    [No Abstract]   [Full Text] [Related]  

  • 44. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
    Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.
    Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1245-55. PubMed ID: 25742516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. All In for Chemical Safety!
    Ernst RA
    Occup Health Saf; 2016 May; 85(5):48-50. PubMed ID: 27311207
    [No Abstract]   [Full Text] [Related]  

  • 47. Maintaining vigilance over quality of EU research.
    Lancet; 1999 Apr; 353(9159):1111. PubMed ID: 10209968
    [No Abstract]   [Full Text] [Related]  

  • 48. Evolution of European Union legislation on emergency research.
    Mentzelopoulos SD; Mantzanas M; van Belle G; Nichol G
    Resuscitation; 2015 Jun; 91():84-91. PubMed ID: 25796997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. European Union Regulations.
    Fürst P
    Methods Mol Biol; 2011; 747():1-20. PubMed ID: 21643902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Open letter to the European Commission: scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles.
    Dietrich D; von Aulock S; Marquardt HW; Blaauboer BJ; Dekant W; Kehrer J; Hengstler JG; Collier AC; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Arch Toxicol; 2013 Sep; 87(9):1739-41. PubMed ID: 23979651
    [No Abstract]   [Full Text] [Related]  

  • 51. [Structures of the European union--possibilities for influence by medical societies].
    Grewe R
    Klin Monbl Augenheilkd; 2005 Nov; 222(11):933-6. PubMed ID: 16308830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement.
    Solecki R; Kortenkamp A; Bergman Å; Chahoud I; Degen GH; Dietrich D; Greim H; Håkansson H; Hass U; Husoy T; Jacobs M; Jobling S; Mantovani A; Marx-Stoelting P; Piersma A; Ritz V; Slama R; Stahlmann R; van den Berg M; Zoeller RT; Boobis AR
    Arch Toxicol; 2017 Feb; 91(2):1001-1006. PubMed ID: 27714423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The chemical within. BPA is everywhere. Is it dangerous? We don't really know.
    Walsh B
    Time; 2011 Dec; 178(23):22. PubMed ID: 22250350
    [No Abstract]   [Full Text] [Related]  

  • 54. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):65-80. PubMed ID: 18333715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advertising of medical devices: foreign experience and Ukrainian practice.
    Pashkov V; Harkusha A; Bytiak O
    Wiad Lek; 2017; 70(3 pt 1):456-461. PubMed ID: 28711887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of European Union legislation of herbal medicinal products and its transposition to national legislation in 1965-2007: case Finland.
    Koski SM; Laitinen-Parkkonen P; Airaksinen M
    Int J Health Plann Manage; 2015; 30(3):260-75. PubMed ID: 24375722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
    Legler J; Fletcher T; Govarts E; Porta M; Blumberg B; Heindel JJ; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1278-88. PubMed ID: 25742518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New EU legislation for risk assessment of GM food: no scientific justification for mandatory animal feeding trials.
    Kuiper HA; Kok EJ; Davies HV
    Plant Biotechnol J; 2013 Sep; 11(7):781-4. PubMed ID: 23786622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A conflict between compulsory reporting in health care and the European Union convention on human rights?].
    Hollstedt C
    Lakartidningen; 2007 Feb 21-27; 104(8):610. PubMed ID: 17396464
    [No Abstract]   [Full Text] [Related]  

  • 60. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.